Addressing the Challenge of Developing a Physiologically Relevant Dissolution Test for Regulatory Purposes

The challenge of developing a physiologically relevant dissolution test to satisfy regulatory agencies has pushed drug manufacturers to engage in “design of experiment” method development, which helps manufacturers address variability, dissolution medium, and surfactant use-all of which will influence dissolution.